0.25 CME. This module provides an overview of the tick borne illness epidemic in the UK and Ireland and the need for international data sharing and collaboration in the field of vector borne illness.

0.5 CME. This course provides a summary of similarities between clinical and biological manifestations of chronic Lyme disease and long COVID. It presents results of a published clinical trial on low dose naltrexone as an agent in long COVID.

0.5 CME. This course provides a summary of clinical and radiological presentations of CNS Lyme Disease.

0.5 CME. This course describes typical neuro-Lyme clinical presentations and discusses the mechanisms of nerve injury that are caused by Lyme disease bacteria. 

0.5 CME. This course provides a summary of a seven year experience of laboratory blood-based testing for tick-borne infections other than Lyme disease at a National Reference Laboratory and is intended to help guide clinical assessment of symptoms and diagnostic testing for tick-borne illnesses. 

1.0 CME. This course provides an overview of the One Health framework for human health clinicians and describes how this framework can be applied in human clinical practice. 

0.5 CME.

0.5 CME. This module provides an overview of fetal risks of untreated Lyme in cases of congenital transmission and background information about related ICD-11 Codes.

0.5 CME. This module provides an overview of perinatal risks and outcomes related to congenital Lyme and co-infections.

0.5 CME. This presentation provides physicians with clinically useful information that will help them assist patients with manifestations of Chronic Lyme disease.

1.0 CME. This module provides an overview of neurological manifestations reported in association with Bartonella spp. infections.

0.5 CME. This module covers a general overview of persistent infection in reservoir and incidental hosts, and immune evasion strategies utilized by the Lyme disease pathogen. Landmark studies on immune suppression by Borrelia are presented. An overview of diagnostic test modalities is discussed, along with recent findings on the variability of antibody responses in humans.  Finally, the correlation of treatment success with immune responses is described.

0.5 CME. This module presents human Lyme disease as a systemic infection with inflammatory pathology. The recommended treatment by two medical associations is covered, with an overview of antibiotic efficacy and a description of antibiotic tolerant-persisters. Findings from nonhuman primate studies are presented, as well as treatment goals and new strategies for eradication of the Lyme disease pathogen.

1.0 CME. Invisible International's Christine Green, MD brings together Monica Embers, PhD ("bench") and Kenneth Liegner, MD ("bedside") in a discussion about borrelia persistence.

1.0 CME. This module provides an overview of the history of Bartonella spp infection, from the discovery of Carrion’s disease in South America through trench fever in WWI and the etiology of cat scratch disease in HIV/AIDS epidemic.

1.0 CME. This module provides an overview of key vectors and modes of transmission associated with Bartonella spp. infection, with special attention to ongoing debates surrounding tick transmission, perinatal transmission, and other modes, like transfusion and needlesticks.

1.0 CME. This module provides an overview of Bartonella spp. infection, both pathogenic and species-adapted, in various hosts and reservoirs, including bats, cats, dogs, and people.

1.0 CME. This module introduces a new postulate of comparative infectious disease for elusive, slow-growing, zoonotic, vector-borne diseases like Bartonella spp infection and describes the comparative features of Bartonellosis in dogs and people with particular attention to geographic and occupational risk factors.

1.0 CME. This module provides an overview of the major factors that influence disease expression resulting from Bartonella spp infection with particular attention to bacterial infection strategies and the histopathological progression of lesions observed in both immunocompetent and severely immunodeficient patients.

1.0 CME. This module describes the advantages and limitations of different diagnostic methodologies for confirmation of Bartonella spp. infection, as well as recent advances in sample enrichment for direct detection of infection of this immune-evasive, slow-growing bacterial infection.